Company intelligence / Profile preview

GIC

Singapore, Singapore

Ownership: Private
Development stage: Other

Overview

GIC is a Singaporean sovereign wealth fund, established in 1981, and one of the world’s largest global investors with an estimated AUM of $744B–$800B as of 2025. It invests in a wide range of sectors and is an active investor in healthcare, biotech, and pharmaceuticals through direct investment and equity stakes but is not itself a biotech or healthcare product company.

Industry: Investors

Partnerships

NovotechUnither PharmaceuticalsI-MabTemasek

Beyond the preview

Go deeper on GIC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GIC.

Explore the full profile